Literature DB >> 21785041

Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients.

Ko Hanai1, Tetsuya Babazono, Naoshi Yoshida, Izumi Nyumura, Kiwako Toya, Toshihide Hayashi, Ryotaro Bouchi, Nobue Tanaka, Akiko Ishii, Yasuhiko Iwamoto.   

Abstract

BACKGROUND: The impact of serum lipid abnormalities on the progression of diabetic kidney disease (DKD) remains conflicting. Furthermore, gender differences in the association between dyslipidaemia and outcome of DKD are largely unknown. We therefore conducted this single-centre observational cohort study to clarify gender differences in the association between serum lipid profiles and the progression of DKD.
METHODS: Seven hundred and twenty-three Japanese type 2 diabetes mellitus (T2DM) patients with normoalbuminuria or microalbuminuria, 280 women and 443 men, with a mean (± SD) age of 63 ± 11 years were studied. The endpoint was the progression to a more advanced stage of albuminuria. For statistical analyses, Cox proportional hazard model analyses were conducted.
RESULTS: During the mean follow-up period of 4.3 years, 62 of 477 patients with normoalbuminuria and 69 of 246 patients with microalbuminuria reached the endpoint. A significant interaction between high-density lipoprotein (HDL) cholesterol and gender was detected (P(interaction) = 0.04); therefore, separate analyses were conducted for men and women. Overall, in men, the univariate Cox proportional hazard model revealed that higher triglycerides and lower HDL cholesterol levels were significantly associated with higher risk of reaching the endpoint. In the multivariate Cox proportional hazard model, only HDL cholesterol levels remained as an independent predictor of the endpoint (hazard ratio 0.391, P = 0.01). In women, no serum lipid parameters were associated with the endpoint.
CONCLUSIONS: Lower HDL cholesterol levels seem to be associated with the progression of DKD in men but not in women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785041     DOI: 10.1093/ndt/gfr417

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  13 in total

1.  Effects of statins on the kidneys in patients with type 2 diabetes.

Authors:  Ko Hanai; Tetsuya Babazono; Yasuko Uchigata
Journal:  Clin Exp Nephrol       Date:  2016-09-15       Impact factor: 2.801

2.  Metabolic syndrome, ESRD, and death in CKD.

Authors:  Sankar D Navaneethan; Jesse D Schold; John P Kirwan; Susana Arrigain; Stacey E Jolly; Emilio D Poggio; Srinivasan Beddhu; Joseph V Nally
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

Review 3.  Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals.

Authors:  Francesca Viazzi; Giuseppina Tiziana Russo; Antonio Ceriello; Paola Fioretto; Carlo Giorda; Salvatore De Cosmo; Roberto Pontremoli
Journal:  J Nephrol       Date:  2018-11-27       Impact factor: 3.902

4.  Association Between Renal Dysfunction and Low HDL Cholesterol Among the Elderly in China.

Authors:  Aijun You; Yaxin Li; Brian Tomlinson; Longfei Yue; Kaijie Zhao; Huimin Fan; Zhongmin Liu; Yuzhen Zhang; Liang Zheng
Journal:  Front Cardiovasc Med       Date:  2021-05-12

5.  Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN rats.

Authors:  Denisha R Spires; Oleg Palygin; Vladislav Levchenko; Elena Isaeva; Christine A Klemens; Sherif Khedr; Oksana Nikolaienko; Alison Kriegel; Xi Cheng; Ji-Youn Yeo; Bina Joe; Alexander Staruschenko
Journal:  Physiol Genomics       Date:  2021-04-19       Impact factor: 4.297

6.  Cohort profile: the German Diabetes Study (GDS).

Authors:  Julia Szendroedi; Aaruni Saxena; Katharina S Weber; Klaus Strassburger; Christian Herder; Volker Burkart; Bettina Nowotny; Andrea Icks; Oliver Kuss; Dan Ziegler; Hadi Al-Hasani; Karsten Müssig; Michael Roden
Journal:  Cardiovasc Diabetol       Date:  2016-04-07       Impact factor: 9.951

7.  Risk factors of gender for renal progression in patients with early chronic kidney disease.

Authors:  Po-Ya Chang; Li-Nien Chien; Yuh-Feng Lin; Mai-Szu Wu; Wen-Ta Chiu; Hung-Yi Chiou
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Exploration of Blood Lipoprotein and Lipid Fraction Profiles in Healthy Subjects through Integrated Univariate, Multivariate, and Network Analysis Reveals Association of Lipase Activity and Cholesterol Esterification with Sex and Age.

Authors:  Yasmijn Balder; Alessia Vignoli; Leonardo Tenori; Claudio Luchinat; Edoardo Saccenti
Journal:  Metabolites       Date:  2021-05-18

Review 9.  Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors.

Authors:  Annalisa Giandalia; Alfio Edoardo Giuffrida; Guido Gembillo; Domenico Cucinotta; Giovanni Squadrito; Domenico Santoro; Giuseppina T Russo
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

10.  High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: Findings from the China Cardiometabolic Disease and Cancer Cohort (4C) Study.

Authors:  Lei Gong; Chuan Wang; Guang Ning; Weiqing Wang; Gang Chen; Qin Wan; Guijun Qin; Li Yan; Guixia Wang; Yingfen Qin; Zuojie Luo; Xulei Tang; Yanan Huo; Ruying Hu; Zhen Ye; Lixin Shi; Zhengnan Gao; Qing Su; Yiming Mu; Jiajun Zhao; Lulu Chen; Tianshu Zeng; Xuefeng Yu; Qiang Li; Feixia Shen; Yinfei Zhang; Youmin Wang; Huacong Deng; Chao Liu; Shengli Wu; Tao Yang; Yufang Bi; Jieli Lu; Mian Li; Yu Xu; Min Xu; Tiange Wang; Zhiyun Zhao; Xinguo Hou; Li Chen
Journal:  Diabetes Obes Metab       Date:  2021-08-16       Impact factor: 6.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.